
MEDIPHARM LABS CORP by Medipharm Labs fell 2.1% from $0.05 to $0.05, behind the S&P 500's +13.3%. Its worst day was Apr 6 (−8.6%), and its low came Nov 28 at $0.04.
Nov 17, 2025 – Nov 13, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
MEDIPHARM LABS CORP by Medipharm Labs closed at its lowest level of the year, 12.9% below where the year started.
−1.6% · S&P 500 +0.5%
EPS of $-0.01 was reported on $7.9M revenue.
Story events cover the past 12 months · Times ET
−1.8% · S&P 500 −0.3%
MEDIPHARM LABS CORP by Medipharm Labs shares rose 9.4%, while the S&P 500 rose 0.0%.
+9.4% · S&P 500 0.0%
MEDIPHARM LABS CORP by Medipharm Labs closed at its highest level of the year, 39.9% above where the year started.
+28.9%, the year's best day · S&P 500 −0.5%
EPS of $0.00 was reported on $6.5M revenue.
+1.1% · S&P 500 +0.6%
EPS of $0.00 was reported on $7.2M revenue.
−0.7% · S&P 500 +0.7%
EPS of $0.00 was reported on $8.4M revenue.
0.0% · S&P 500 −0.4%
Where it ended: a close of $0.05 on Nov 13, 2026.
Nothing in the past 12 months.
All MEDIF analyst actionsNothing in the past 12 months.
All MEDIF dividend history